I am a physician-scientist with a long-standing interest in blood cancers. I received my undergraduate degree at University of Halle-Wittenberg and medical degree at University of Heidelberg in Germany where I developed an interest in blood cancer research. I joined the Hofmann-Nowak laboratory to study clonal evolution of myeloid malignancies using primary human samples and published my work in multiple first author and co-author papers. I completed my residency training in hematology and oncology at University of Heidelberg and moved to the United States to pursue my postdoctoral studies in Dr. Zuzana Tothova’s laboratory at the Dana-Farber Cancer Institute. My work in the Tothova lab focuses on mechanistic studies of epigenetic dysregulation during disease progression of cohesin-mutant MDS and AML. I aspire to solve clinically relevant basic science questions and wish to dedicate my career to improving outcomes for patients with myeloid malignancies.